葡萄糖和胰岛素不同调节葡萄糖原性和尿原性基因表达
Kanako Deguchi1, Chihiro Ushiroda1, Yuka Kamei2
1Department of Clinical Nutrition, Fujita Health University.
Journal of nutritional science and vitaminology
|March 2, 2025
概括
胰岛素,而不是葡萄糖,调节尿素生成. 胰岛素和葡萄糖对葡萄糖生成基因表达有相反的影响,影响小鼠的关键代谢途径.
科学领域:
- 代谢调节 代谢调节 代谢调节
- 基因表达分析 基因表达分析
- 肝脏通路 肝脏通道
背景情况:
- 葡萄糖和胰岛素通过ChREBP和SREBP1c激活糖解和脂质生成.
- 葡萄糖和胰岛素在调节葡萄糖和尿素基因中的不同作用尚未完全理解.
研究的目的:
- 研究胰岛素信号传递和ChREBP在调节肝脏基因表达中的不同作用.
- 为了比较胰岛素抗剂 (S961) 和Chrebp删除对代谢途径的影响.
主要方法:
- 使用一种胰岛素抗剂 (S961) 和被删除Chrebp的小鼠模型.
- 分析了肝脏基因表达的糖解,脂质生成,葡萄糖生成和尿素生成.
- 测量了血代谢物和肝脏甘油三含量.
主要成果:
- S961增加了血葡萄糖和胰岛素;Chrebp删除没有添加效应.
- 无论是S961还是Chrebp的删除都降低了糖分和脂质基因表达.
- S961上调调节了葡萄糖基因,而Chrebp删除除了大多数下调调节,除了Pck1.1.
- S961增加了尿素基因表达和改变了相关代谢物度;Chrebp删除没有影响.
结论:
- 胰岛素,而不是葡萄糖,主要调节尿素基因表达.
- 胰岛素和葡萄糖对糖原基因表达产生相反的调节作用.
相关概念视频
Hormones Regulating Blood Glucose
3.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.0K
Cell Specific Gene Expression
13.4K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.4K
Glucose Homeostasis: Regulation of Blood Glucose
1.4K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.0K
Insulin: The Receptor and Signaling Pathways
1.1K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.1K
Glucagon-like Receptor Agonists
290
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
290


